暴露于组织等离子体激活剂的孕妇中纤维解质活性的变化:采用旋转血栓凝聚仪的体外研究
1City University of New York School of Medicine, New York, NY 10031, USA; Department of Anesthesiology, Pain and Perioperative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
International journal of obstetric anesthesia
|April 17, 2024
概括
产科患者表现出纤维解质的显著变化,对组织等离子素激活剂 (tPA) 的反应不同. 这项研究探讨了这些纤维素分析表型的潜在点照顾应用.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 血栓形成和血液静止.
背景情况:
- 尽管与产后出血有关,但在产科患者中纤维素分解的变异性尚未得到充分研究.
- 研究母体血液中的纤维解质对于理解产科并发症至关重要.
研究的目的:
- 为了研究母体血液样本中的纤维素分解的体外变异性.
- 用旋转性血小板电流学 (ROTEM) 分析纤维解质,并通过组织等离子素激活剂 (tPA) 刺激.
- 探索产科纤维素分析表型的潜在分类.
主要方法:
- 从19名妊娠期患者收集了全血样.
- 组织等离子体激活剂 (tPA) 被添加到100或220 ng/mL的度.
- 旋转性血小板造影仪 (ROTEM) 用于测量纤维素分解参数.
主要成果:
- 观察到对凝块稳定性和溶解的显著个体内变异.
- 患者对tPA表现出不同的反应,从没有溶解到完全凝块分解.
- 在两种tPA度下,在溶解参数 (LI30) 中观察到高变量系数 (CV).
结论:
- 在产科人群中存在对外源tPA的纤维解质反应的广泛范围.
- 患者的子组被确定为对tPA的高度响应或不敏感.
- 需要进行进一步的研究,以开发在护理地点对溶解易感性的预测模型.
相关概念视频
Clot Retraction and Fibrinolysis
5.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689


